Epidemiological Aspects of Migraine

  • W. E. Waters


The extensive literature on migraine often mentions its epidemiology. However, almost all these references refer to information derived from selected series of patients with migraine who are seen by doctors with a particular interest in the condition. Whether they are representative of all migraine sufferers is not known. It is likely that patients in such series have more severe, or more frequent, attacks than other individuals with migraine and it may be that they are also different in other respects. One of the difficulties, in elucidating the epidemiology of migraine in a series of patients attending a clinic, is to get suitable “controls”. It is of little help to find out the distribution of blood pressure, or the percentage with a family history of migraine, in migraine patients unless these can be compared with similar data from controls. But who, it may be asked, is a suitable control for such a migraine patient? Is it someone without migraine who attends a doctor? If so, should it be the same doctor? Is it someone without migraine who does not attend a doctor? It can be seen that the problem of selecting suitable controls is difficult as the controls are likely to be different with each of these methods.


Ergot Alkaloid Suitable Control World Federation Epidemiological Aspect Migraine Sufferer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Ad Hoc Committee on Classification of Headache (1962). Classification of Headache. J. Amer. med. Ass. 179, 717.CrossRefGoogle Scholar
  2. Berde, B., Cerletti, A., Dengler, H. J. and Zoglio, M. A. (1970). Studies of the interaction between ergot alkaloids and scanthine derivatives. In Background to Migraine. London: William Heinemann Medical Books.Google Scholar
  3. Waters, W. E. (1970a). Community studies of the prevalence of headache. Headache 9, 178.CrossRefGoogle Scholar
  4. Waters, W. E. (1970b). Controlled clinical trial of ergotamine tartrate. Brit. med. J. 2, 325.CrossRefGoogle Scholar
  5. Waters, W. E. (1970c). Headache and the eye. Lancet ii, 1.CrossRefGoogle Scholar
  6. Waters, W. E. and O’Connor, P. J. (1970). The clinical validation of a headache questionnaire. In Background to Migraine. London, William Heinemann Medical Books.Google Scholar
  7. World Federation of Neurology (1970). Definition of migraine. In Background to Migraine. London: William Heinemann Medical Books.Google Scholar

Copyright information

© Springer Science+Business Media New York 1971

Authors and Affiliations

  • W. E. Waters

There are no affiliations available

Personalised recommendations